Project Grant R21HD115117
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$263K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $1,435,204 to the University of Texas Medical Branch at Galveston (UTMB) from June 1, 2024 to March 31, 2029. The funding supports research to assess the efficacy of the non-mammalian disaccharides trehalose and lactotrehalose in preventing and treating preeclampsia, a leading cause of maternal and fetal...
The National Institute of Child Health and Human Development (NICHD) awarded a $250,500 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant, titled "Impaired Renal Reserve and Preeclampsia," runs from August 1, 2024 to July 31, 2026. The project will use state-of-the-art methods, including in vivo plasma volume measurements, uterine artery blood flow measurements, preeclampsia biomarkers,...
The National Institute of Child Health and Human Development awarded a $293,756 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Institute for Systems Biology to conduct research on understanding the molecular mechanisms associated with common obstetric disorders like preeclampsia, preterm birth, and fetal growth restriction. The project aims to leverage placental multiomics data, including metabolomic, proteomic, and transcriptomic analyses, to...
The National Institute of Child Health and Human Development (NICHD) awarded a $717,871 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Magee-Womens Research Institute and Foundation in Pittsburgh, PA, effective August 13, 2024. The overarching goal of the project is to develop non-invasive liquid biopsy screening methods to detect and predict preterm birth, preeclampsia, and intrauterine growth restriction. The research involves analyzing cell-free...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is funding research to develop a targeted, placenta-tropic lipid nanoparticle (LNP) platform for delivering therapeutic mRNA cargo to treat pre-eclampsia, a serious pregnancy complication. The $349,375 award to The Trustees of the University of Pennsylvania will support a multi-year effort to screen novel...
This federal Project Grant award of $234,000.00 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to investigate the functional importance of a novel NF-kB genetic variant (rs230511) in preeclampsia. The grant will combine human physiological studies with CRISPR-Cas9 gene editing to explore how this variant influences inflammatory responses and impairs uteroplacental vascular...
The federal Project Grant award R01HD112930, totaling $632,110, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research aimed at "Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia", a major public health issue accounting for significant maternal complications and long-term cardiovascular disease...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research on the neuroprotective actions of the apelinergic axis in the long-term cerebrovascular consequences of preeclampsia. The award of $232,500 was made on August 13, 2024 to Wake Forest University Health Sciences, a private, non-profit academic medical center. The research will utilize...